Related Experiment Videos
Electrocardiographic changes in patients receiving neuroleptic medication
J P Warner1, T R Barnes, J A Henry
1University Department of Psychiatry, Royal Free Hospital School of Medicine, London, UK.
Acta Psychiatrica Scandinavica
|April 1, 1996
Summary
Neuroleptic medications can cause prolonged QTc intervals, a heart rhythm change linked to serious cardiac issues. High doses increase this risk, suggesting careful cardiac monitoring for patients on these drugs.
Area of Science:
- Cardiology
- Psychopharmacology
- Clinical Medicine
Background:
- Sudden death in neuroleptic users is a concern, with cardiac arrhythmias suspected.
- Electrocardiographic (ECG) changes may predict these arrhythmias.
Purpose of the Study:
- To investigate the association between neuroleptic medication and ECG changes.
- To identify specific ECG predictors of malignant cardiac arrhythmias in patients using neuroleptics.
Main Methods:
- Electrocardiographs were recorded from 111 neuroleptic patients and 42 controls.
- Statistical analysis was used to compare ECG parameters between groups.
Main Results:
- Prolonged QTc intervals were more frequent in patients on neuroleptic medication.
- QTc interval prolongation was significantly associated with daily doses exceeding 2000 mg chlorpromazine equivalents (OR 4.28, P < 0.02).
- QTc dispersion was not significantly increased in the patient group.
Conclusions:
- Neuroleptic medication is linked to ECG changes, specifically prolonged QTc intervals.
- High-dose neuroleptic therapy poses a greater risk for these cardiac alterations.
- These findings highlight the need for cardiac monitoring in patients receiving neuroleptics.